2-fluoropropionyl-labeled pegylated dimeric rgd peptide

Small moleculeexperimentalImaging agent

Chemistry & pharmacology

Imaging
18-fluorine

Oral

No

Parenteral

No

Topical

No

Also known as

  • 2-fluoropropionyl-labeled pegylated dimeric rgd peptide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01806675Phase 1/Phase 2 (Phase 2)Mar 1, 2013National Cancer Institute (NCI), Stanford University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government1012013
Stanford UniversityAcademic/Hospital1112013
2 organizations
Page 1 / 1